These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 857275)
1. The effect of a 10 cm2, 0.5% 15-ME-PGF2alpha methyl ester intravaginal silastic device on abortion and plasma prostaglandin concentration. Lauersen NH; Wilson KH Prostaglandins; 1977 Apr; 13(4):755-62. PubMed ID: 857275 [TBL] [Abstract][Full Text] [Related]
2. Hormone release and abortifacient effectiveness of a newly developed silastic device containing 15-ME-PGF2alpha methyl ester in concentrations of 0.5% and 1.0%. Lauersen NH; Wilson KH Prostaglandins; 1976; 12 Suppl():63-79. PubMed ID: 968066 [TBL] [Abstract][Full Text] [Related]
3. Midtrimester abortion induced by single intra-amniotic instillation of two dose schedules of 15(S)-15-methyl-prostaglandin F2alpha. Lauersen NH; Wilson KH Prostaglandins; 1975 Apr; 9(4):617-25. PubMed ID: 1153812 [TBL] [Abstract][Full Text] [Related]
4. Prostaglandins and abortion. III. Comparison of single intra-amniotic injections of 15-methyl prostaglandin F2alpha and prostaglandin F2alpha for termination of second-trimester pregnancy: an international multicenter study. World Health Organization Tast Force on the Use of Prostaglandins forthe Regulation of Fertility. Am J Obstet Gynecol; 1977 Nov; 129(6):601-6. PubMed ID: 920761 [TBL] [Abstract][Full Text] [Related]
6. Induction of midtrimester abortion by serial intravaginal administration of 15(S)-15-methyl-prostaglandin F2alpha (THAM) suppositories. Lauersen NH; Wilson KH Prostaglandins; 1975 Dec; 10(6):1037-45. PubMed ID: 1208882 [TBL] [Abstract][Full Text] [Related]
7. The abortifacient effectiveness and plasma prostaglandin concentrations with 15(S)-15-methyl prostaglandin F2alpha methyl ester-containing vaginal silastic devices. Lauersen NH; Wilson KH Fertil Steril; 1976 Dec; 27(12):1366-73. PubMed ID: 1001521 [TBL] [Abstract][Full Text] [Related]
8. Midtrimester abortion with intramuscular injection of 15-methyl-prostaglandin F2alpha. Slaughter L; Ballard CA Contraception; 1975 May; 11(5):533-40. PubMed ID: 1139940 [TBL] [Abstract][Full Text] [Related]
9. Mid-trimester abortion with intra-amniotic prostaglandin F2 alpha and intravenous oxytocin infusion. Salomy M; Halbrecht I; London R Prostaglandins; 1975 Feb; 9(2):271-9. PubMed ID: 1135439 [TBL] [Abstract][Full Text] [Related]
10. Intra-amniotic urea and prostaglandin F2alpha for midtrimester abortion: clinical and laboratory evaluation. King TM; Dubin NH; Atienza MF; Burkman RT; Blake DA; Baros NA Am J Obstet Gynecol; 1977 Dec; 129(7):817-24. PubMed ID: 75692 [TBL] [Abstract][Full Text] [Related]
11. The abortifacient and oxytocic effects of an intravaginal silicone rubber device containing a 0.5% concentration of 15(S)-15-methyl-prostaglandin F2alpha methyl ester. Lauersen NH; Wilson KH Am J Obstet Gynecol; 1977 Apr; 127(7):784-7. PubMed ID: 848532 [TBL] [Abstract][Full Text] [Related]
12. Serial intramuscular injections of 15(S)-15-methyl-prostaglandin F2alpha in the induction of abortion. Lauersen NH; Wilson KH Prostaglandins; 1975 Dec; 10(6):1029-36. PubMed ID: 1208881 [TBL] [Abstract][Full Text] [Related]
13. Prostaglandins and abortion. I. intramuscular administration of 15-methyl prostaglandin F2alpha for induction of abortion in weeks 10 to 20 of pregnancy. World Health Organization Task Force on the Use of Prostaglandins for the Regulation of Fertility. Am J Obstet Gynecol; 1977 Nov; 129(6):593-6. PubMed ID: 920759 [TBL] [Abstract][Full Text] [Related]
14. Clinical observations with a prostaglandin-containing silastic vaginal device for pregnancy termination. Hendricks CH; Dingfelder JR; Gruber WS Prostaglandins; 1976; 12 Suppl():99-122. PubMed ID: 968068 [TBL] [Abstract][Full Text] [Related]
15. Midtrimester abortion induced by serial intravaginal administration of prostaglandin E2 suppositories in conjunction with a contraceptive diaphragm. Lauersen NH; Wilson KH Prostaglandins; 1975 Jul; 10(1):139-50. PubMed ID: 1153798 [TBL] [Abstract][Full Text] [Related]
16. Termination of midtrimester pregnancy by serial intramuscular injections of 15(S)-15-methyl-prostaglandin F2alpha. Lauersen NH; Wilson KH Am J Obstet Gynecol; 1976 Jan; 124(2):169-76. PubMed ID: 1247053 [TBL] [Abstract][Full Text] [Related]
17. Second-trimester termination with 16,16 dimethyl-PGE1-methyl ester (gemeprost), compared with a regimen that included intra-amniotic PGF2 alpha and hypertonic saline. Waldron KW; Renou PM; Lolatgis N; Morris ND; Mamers PM; Oldham J; Healy DL Reprod Fertil Dev; 1990; 2(5):495-8. PubMed ID: 2075246 [TBL] [Abstract][Full Text] [Related]
18. Cervical dilatation with prostaglandin analogues prior to vaginal termination of first trimester pregnancy in nulliparous patients. Karim SM; Choo HT; Cheng P Prostaglandins; 1975 Apr; 9(4):631-8. PubMed ID: 1153813 [TBL] [Abstract][Full Text] [Related]
19. Termination of second trimester pregnancy with intra-amniotic 15 (S) 15 methyl prostaglandin F-2alpha - a two dose schedule study. Karim SM; Sivasamboo R Prostaglandins; 1975 Mar; 9(3):487-94. PubMed ID: 1138305 [TBL] [Abstract][Full Text] [Related]
20. Mid-trimester abortion with 15 (S) methyl prostaglandin F 2 alpha. Leibman T; Saldana L; Schulman H; Cunningham MA; Randolph G Prostaglandins; 1974 Sep; 7(5):443-8. PubMed ID: 4424912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]